NMGAX
Price
$14.97
Change
+$0.09 (+0.60%)
Updated
Apr 17 closing price
Net Assets
1.62B
VMGIX
Price
$92.26
Change
+$0.51 (+0.56%)
Updated
Apr 17 closing price
Net Assets
27.18B
Ad is loading...

NMGAX vs VMGIX

Header iconNMGAX vs VMGIX Comparison
Open Charts NMGAX vs VMGIXBanner chart's image
Neuberger Berman Mid Cap Growth A
Price$14.97
Change+$0.09 (+0.60%)
VolumeN/A
Net Assets1.62B
Vanguard Mid-Cap Growth Index Investor
Price$92.26
Change+$0.51 (+0.56%)
VolumeN/A
Net Assets27.18B
NMGAX vs VMGIX Comparison Chart
Loading...
View a ticker or compare two or three
VS
NMGAX vs. VMGIX commentary
Apr 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NMGAX is a Buy and VMGIX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
VMGIX has more cash in the bank: 27.2B vs. NMGAX (1.62B). VMGIX pays higher dividends than NMGAX: VMGIX (0.59) vs NMGAX (0.00). NMGAX was incepted earlier than VMGIX: NMGAX (16 years) vs VMGIX (19 years). NMGAX (1.06) is less costly to investors than VMGIX (0.19). NMGAX is a more actively managed with annual turnover of: 97.00 vs. VMGIX (14.00). NMGAX has a lower initial minimum investment than VMGIX: NMGAX (1000) vs VMGIX (3000). VMGIX annual gain was more profitable for investors over the last year : 5.29 vs. NMGAX (-7.58). VMGIX return over 5 years is better than : 63.07 vs. NMGAX (2.48).
NMGAXVMGIXNMGAX / VMGIX
Total Expense Ratio1.060.19558%
Annual Report Gross Expense Ratio1.060.19558%
Fund Existence16 years19 years-
Gain YTD-11.848-8.073147%
Front Load6%N/A-
Min. Initial Investment1000300033%
Min. Initial Investment IRAN/AN/A-
Net Assets1.62B27.2B6%
Annual Yield % from dividends0.000.59-
Returns for 1 year-7.585.29-143%
Returns for 3 years-6.8810.53-65%
Returns for 5 years2.4863.074%
Returns for 10 years3.28117.513%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
IDYA17.080.90
+5.56%
IDEAYA Biosciences
PRLD0.810.04
+5.19%
Prelude Therapeutics
FCFS121.441.38
+1.15%
FirstCash Holdings
EGHT1.58N/A
N/A
8x8
INFY16.14-0.44
-2.65%
Infosys Limited